Protagenic Therapeutics, Inc.
Income Statement
| Line Item | FY2015 | FY2014 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $456.3K | $42.0K |
| SG&A Expense | $568.8K | $975.0K |
| Operating Income | $-1.0M | $-975.0K |
| Operating Margin | — | — |
| Interest Expense | $11.5K | $3.0K |
| Pretax Income | $-1.0M | $-924.0K |
| Income Tax Expense | $0 | $0 |
| Net Income | $-1.0M | $-1.1M |
| Net Margin | — | — |
| EPS (Basic) | $-0.15 | $0.00 |
| EPS (Diluted) | $-0.15 | $0.00 |
| Shares Outstanding (Basic) | 6.6M | 400.0M |
| Shares Outstanding (Diluted) | 6.6M | 400.0M |
| Dividends Per Share | — | — |